These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14952179)

  • 21. Misleading heparin monitoring leading to protamine sulphate in patient with lupus anticoagulant.
    Wanger GP; Roberts W; Brandt J
    Lancet; 1981 Nov; 2(8255):1112. PubMed ID: 6118557
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the mechanism of action of protamine-sulfate on some indices of blood coagulation system].
    Skipetrov VP
    Farmakol Toksikol; 1966; 29(2):188-92. PubMed ID: 6000344
    [No Abstract]   [Full Text] [Related]  

  • 23. Activation of coagulation by heparin-protamine complexes as demonstrated by thrombotest.
    Godal HC; Gjengedal G
    Scand J Haematol; 1971; 8(3):194-9. PubMed ID: 5093996
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
    Khan NU; Wayne CK; Barker J; Strang T
    Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood clotting in dogs after intravenous injection of protamine].
    QUIVY D
    C R Seances Soc Biol Fil; 1948 Nov; 142(21-22):1402-4. PubMed ID: 18114908
    [No Abstract]   [Full Text] [Related]  

  • 26. Complications of heparin therapy.
    Gervin AS
    Surg Gynecol Obstet; 1975 May; 140(5):789-96. PubMed ID: 1170648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): an in vitro study.
    Mittermayr M; Margreiter J; Velik-Salchner C; Klingler A; Streif W; Fries D; Innerhofer P
    Br J Anaesth; 2005 Sep; 95(3):310-6. PubMed ID: 16024582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protamine sulfate neutralization of lactobionic acid amides.
    Hoppensteadt D; Walenga JM; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 2():153-7. PubMed ID: 1948086
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of protamine sulfate on clot formation time and clot strength thromboelastography variables for canine blood samples.
    Bailey CJ; Koenigshof AM
    Am J Vet Res; 2014 Apr; 75(4):338-43. PubMed ID: 24669916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of activated coagulation time to monitor heparin during cardiac surgery.
    Roth JA; Cukingnan RA; Scott CR
    Ann Thorac Surg; 1979 Jul; 28(1):69-72. PubMed ID: 454047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A protamine titration as an indication of a clotting defect in certain hemorrhagic states.
    ALLEN JG; MOULDER PV
    J Lab Clin Med; 1949 Apr; 34(4):473-6. PubMed ID: 18116308
    [No Abstract]   [Full Text] [Related]  

  • 32. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation.
    Massonnet-Castel S; Pelissier E; Bara L; Terrier E; Abry B; Guibourt P; Swanson J; Jaulmes B; Carpentier A; Samama M
    Haemostasis; 1986; 16(2):139-46. PubMed ID: 3710291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the activated coagulation time and heparin dose-response curve for the determination of protamine dosage in vascular surgery.
    Szalados JE; Ouriel K; Shapiro JR
    J Cardiothorac Vasc Anesth; 1994 Oct; 8(5):515-8. PubMed ID: 7803739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal bleeding; further clinical experience with toluidine blue and protamine sulfate.
    ALLEN JG; GROSSMAN BJ
    Surg Gynecol Obstet; 1949 Dec; 89(6):692-703. PubMed ID: 15393575
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental studies of heparin-protamine activity with special reference to protamine inhibition of clotting.
    ANDERSEN MN; MENDELOW M; ALFANO GA
    Surgery; 1959 Dec; 46():1060-8. PubMed ID: 13793331
    [No Abstract]   [Full Text] [Related]  

  • 36. Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: results of a randomized double-blind controlled pilot study.
    Koster A; Börgermann J; Gummert J; Rudloff M; Zittermann A; Schirmer U
    Clin Appl Thromb Hemost; 2014 Apr; 20(3):290-5. PubMed ID: 23564056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery.
    DeLaria GA; Tyner JJ; Hayes CL; Armstrong BW
    Arch Surg; 1994 Sep; 129(9):944-50; discussion 950-1. PubMed ID: 8080377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium heparin neutralization and the anticoagulant effects of protamine sulfate.
    Adkins JR; Hardy JD
    Arch Surg; 1967 Feb; 94(2):175-7. PubMed ID: 6016262
    [No Abstract]   [Full Text] [Related]  

  • 40. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.